Inclusion criterea

The status of the patients is evaluated regarding couple of criteria

 Regarding the disease:
  • Patients with metastases to the peritoneum (carcinomatosis)
  • Patients without metastases outside the abdomen organs (lung, bone marrow)
  • Patients with  up to 5 liver metastases can be treated
  • Patients in good condition
  • Patients with  absence of severe concomitant diseases (such as heart, kidney, liver or lungs).
How do we evaluate the patient for surgery + HIPEC
    Volume disease
  • The success of treatment is determined by the complete removal of the tumor tissue, which is highly dependent on the volume and location of the disease.
  • In order to measure the volume of the disease, the location and the predicted success are used peritoneal carcinomatosis index (PCI).
  • We use a PET scan,  computer  tomography (CT), magnetic resonance imaging (MRI). Sometimes laparoscopy performed for more accurate evaluation.
    Required documents
  • To select the best treatment for each individual patient need the following data:
  • History of present illness
  • Summary of chemotherapy (medical history)
  • Summary of radiotherapy (medical history)
  • Medical history of surgery